Fosamax and Bone Problems
The New England Journal of Medicine has recently published a study which showed that the safety in the long term use of bisphosphonate drugs, like Fosamax, for osteoporosis treatment may be in question. The study suggested that in two separate case theories, there has been a link between prolonged bisphosphonate therapy and atypical fractures. There was one study which showed a number patients sustained low-energy non-vertebral fractures while receiving long-term alendronate therapy; three were fractures of the femoral shaft.
Also the study showed that bone biopsies in the patients showed evidence of severely suppressed bone turnover and fracture healing that was delayed or not there at all. Fosamax is actually suppress bone turnover and thus might be associated with accumulated micro-damage in bone in theory.This may be the reason why Fosamax lawsuits continue to increase.
